Robert Francis Doman
Plus aucun poste en cours
Profil
Robert Francis Doman formerly worked at DUSA Pharmaceuticals, Inc., as President & Chief Executive Officer from 2005 to 2011, Echo Therapeutics, Inc., as Executive Chairman & Chief Executive Officer from 2013 to 2014, Celsus Therapeutics Plc, as Independent Director from 2013 to 2015, Bristol Myers Squibb Co., as Vice President-US Operations-Convatec Division from 1991 to 1999, West Pharmaceutical Services, Inc., as President-Device Product Development from 1999 to 2000, and Leach Technology Group, Inc., as President from 2000 to 2004.
Mr. Doman received his undergraduate degree from St. Joseph's University.
Anciens postes connus de Robert Francis Doman
| Sociétés | Poste | Fin |
|---|---|---|
Celsus Therapeutics Plc
 Celsus Therapeutics Plc Pharmaceuticals: MajorHealth Technology Celsus Therapeutics Plc is a drug development company, which focuses on developing novel, first-in-class, non-steroidal, synthetic anti-inflammatory drugs and multi-functional anti-inflammatory drugs. The company main clinical candidates are MRX-5, MRX-6, MRX-4, CFX-1 and OPX-1. Celsus Therapeutics was founded on October 7, 2004 and is headquartered in London, the United Kingdom. | Directeur/Membre du Conseil | 15/07/2015 |
Leach Technology Group, Inc.
 Leach Technology Group, Inc. Medical SpecialtiesHealth Technology Part of TransDigm Group, Inc., Leach Technology Group, Inc. is a manufacturer of medical equipment. The company is based in Indianapolis, IN. | President | 01/01/2004 |
| WEST PHARMACEUTICAL SERVICES, INC. | Corporate Officer/Principal | 01/01/2000 |
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | 01/01/1999 |
| ECHO THERAPEUTICS, INC. | Directeur Général | 30/06/2014 |
Formation de Robert Francis Doman
| St. Joseph's University | Undergraduate Degree |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
| WEST PHARMACEUTICAL SERVICES, INC. | Health Technology |
| Entreprise privées | 4 |
|---|---|
DUSA Pharmaceuticals, Inc.
 DUSA Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology DUSA Pharmaceuticals, Inc. is an integrated dermatology pharmaceutical company, which develops and markets Levulan Photodynamic Therapy technology platform for the prevention and treatment of dermatological skin conditions. Its products include levulan kerastick, BLU-U and clindareach. The company was founded by D. Geoffrey Shulman on February 21, 1991 and is headquartered in Wilmington, MA. | Health Technology |
Celsus Therapeutics Plc
Celsus Therapeutics Plc Pharmaceuticals: MajorHealth Technology Celsus Therapeutics Plc is a drug development company, which focuses on developing novel, first-in-class, non-steroidal, synthetic anti-inflammatory drugs and multi-functional anti-inflammatory drugs. The company main clinical candidates are MRX-5, MRX-6, MRX-4, CFX-1 and OPX-1. Celsus Therapeutics was founded on October 7, 2004 and is headquartered in London, the United Kingdom. | Health Technology |
Leach Technology Group, Inc.
Leach Technology Group, Inc. Medical SpecialtiesHealth Technology Part of TransDigm Group, Inc., Leach Technology Group, Inc. is a manufacturer of medical equipment. The company is based in Indianapolis, IN. | Health Technology |
Echo Therapeutics, Inc.
 Echo Therapeutics, Inc. Medical SpecialtiesHealth Technology Echo Therapeutics, Inc. is a medical device company, which engages in the development of non-invasive, and wireless continuous glucose monitoring system for use in the diabetes outpatient market. It offers needle-free skin preparation device as a platform technology that allows for enhanced skin permeation enabling extraction of analytes, such as glucose and delivery of topical pharmaceuticals. The company was founded in 1989 and is headquartered in Iselin, NJ. | Health Technology |